A Study to Evaluate Dostarlimab Plus Carboplatin-paclitaxel Versus Placebo Plus Carboplatin-paclitaxel in Participants With Recurrent or Primary Advanced Endometrial Cancer
Clinical trial NCT03981796 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT03981796
- Sponsor
- Tesaro, Inc.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-07-18
- Primary completion
- 2026-11-26
- Enrollment
- 785
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.